Advertisement
News
Subscribe to MDT Magazine News

New Pfizer academic-industrial partnership program based in Cambridge

November 16, 2010 6:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Pharmaceutical giant Pfizer Inc. today has established a new network of academic centers that will serve as a "farm team" for drug development. The Global Centers for Therapeutic Innovation is basing its headquarters in Cambridge and will establish partnerships with academic centers...

AdvanSource Biomaterials to be delisted

November 16, 2010 6:36 am | by Mass High Tech: The Journal of New England Technology | Comments

AdvanSource Biomaterials Corp., a maker of polymer technologies for medical devices, has said it will not appeal the New York Stock Exchange's decision to delist the company from its Amex exchange.

Treating heart attack with fat-derived stem cells may be safe in humans

November 16, 2010 5:40 am | by EurekAlert | Comments

(American Heart Association) Treating heart attack patients with regenerative stem cells obtained from their own fat deposits may be feasible and safe, according to a small, first-of-its-kind study. Heart muscle damage in stem cell-treated patients decreased more than half after...

TOPICS:
Advertisement

Verastem secures $16M first round funding

November 16, 2010 5:39 am | by Mass High Tech: The Journal of New England Technology | Comments

Verastem Inc., an early stage biotech company that aims to target cancer stem cells, has landed a $16 million Series A financing, with lead backing from Longwood Founders Fund, and additional support from Bessemer Venture Partners, Cardinal Partners and MPM Capital.

Wide Genetic Testing for Lynch Syndrome Cost Effective

November 16, 2010 5:32 am | by AACR | Comments

PHILADELPHIA — Genetic testing for Lynch Syndrome has always been the most effective strategy for identifying those at risk for colorectal or endometrial cancer, but cost has been a major hurdle. New findings in Cancer Prevention Research, a journal of the American Association for Cancer...

TOPICS:

Reportlinker Adds Global Ambulatory & Bathroom Aids Industry

November 16, 2010 4:37 am | by Bio-Medicine.Org | Comments

NEW YORK, Nov. 16, 2010 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Ambulatory & Bathroom Aids Industry http://www.reportlinker.com/p090638/Global-Ambulatory--Bathroom-Aids-Industry.html This report analyzes the worldwide...

TOPICS:

Pfizer Launches Global Centers for Therapeutic Innovation, a Network of Research Partnerships, With University of California, San Francisco

November 16, 2010 4:36 am | by Bio-Medicine.Org | Comments

NEW YORK, Nov. 16, 2010 /- Pfizer Inc. (NYSE: PFE ) today announced the establishment of the Global Centers for Therapeutic Innovation, an entrepreneurial network of partnerships with leading academic medical centers to transform research and development by accessing leading translational...

TOPICS:

Uptake Medical Names J.C. MacRae as Chief Financial Officer

November 16, 2010 4:36 am | by Bio-Medicine.Org | Comments

IRVINE, Calif., Nov. 16, 2010 /- Uptake Medical Corp. , the leading developer of medical technologies for interventional emphysema therapy , announced today that J.C. MacRae has joined the company as its vice president and chief financial officer. MacRae comes to Uptake Medical with over...

TOPICS:
Advertisement

Clinical Experts Describe Radiosurgical Advances for Brain, Breast, and Spinal Cancers

November 16, 2010 4:36 am | by Bio-Medicine.Org | Comments

PALO ALTO, Calif., Nov. 16, 2010 /- Talks on major advances in radiosurgery and radiotherapy for treating cancer of the brain, breast, and spine, captured the attention of more than 800 clinicians at Varian Medical Systems' 2010 Annual Users Meeting, held recently in conjunction with the...

TOPICS:

At RSNA, eMix to Exhibit EMR Delivery, Other New Features

November 16, 2010 4:34 am | by Bio-Medicine.Org | Comments

CHICAGO, Nov. 16, 2010 /- eMix , a new business venture incubated by DR Systems , will be exhibiting new features of its cloud-based image sharing technology for studies and reports at RSNA 2010 . eMix is also announcing its expansion into the European marketplace, starting in Germany,...

TOPICS:

Argon Medical Devices Announces Exclusive License and Distribution Agreement for 'UltraStream™' Chronic Hemodialysis Catheter

November 16, 2010 2:34 am | by Bio-Medicine.Org | Comments

ATHENS, Texas, Nov. 16, 2010 /- Argon Medical Devices, Inc. announced today that it has entered into a definitive licensing agreement with Rex Medical, LP ("Rex Medical") for exclusive rights to market and distribute the UltraStream chronic dialysis catheter ™ on a global basis....

TOPICS:

iFuse Implant System™ Receives CE Mark

November 15, 2010 11:40 pm | by Bio-Medicine.Org | Comments

SAN JOSE, Calif., Nov. 15, 2010 /- SI-BONE, Inc. (San Jose, California), a medical device company that is pioneering the use of a minimally invasive surgical (MIS) device to treat the sacroiliac (SI) joint announced today that it has received a CE mark for its iFuse Implant System™....

TOPICS:

Pathfinder Initiates Minimally Invasive Surgical Navigation Study

November 15, 2010 11:40 pm | by Bio-Medicine.Org | Comments

NASHVILLE, Tenn., Nov. 15, 2010 /- Pathfinder Therapeutics, Inc. has initiated a clinical study to assess the value of Explorer™, its image-guided surgical platform, in minimally invasive liver resections and ablations.  Clinical sites participating in the study include:...

TOPICS:

U.S. District Court Rules from Bench in Lilly's Favor, Confirms Validity of Alimta Patent

November 15, 2010 11:40 pm | by Bio-Medicine.Org | Comments

INDIANAPOLIS, Nov. 15, 2010 /- Eli Lilly and Company (NYSE: LLY ) today announced that the trial on the validity of the compound patent for Alimta® (pemetrexed for injection) before the U.S. District Court for the District of Delaware ended this afternoon with a ruling from the court...

TOPICS:

The Spatz Adjustable Balloon System® for Weight Loss Becomes the First Intragastric Balloon to Receive Regulatory Approval for 1 Year Implantation Time

November 15, 2010 11:38 pm | by Bio-Medicine.Org | Comments

JERICHO, N.Y., Nov. 16, 2010 /- Following results of its 12 month study in Europe, Spatz FGIA, Inc . has received regulatory approval for extension of the implantation period from six months to 12 months. Intragastric balloons for weight loss have been used successfully for the last 17...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading